NCT04731038 2021-09-17Combination Therapy for First Line Treatment of Advanced Cervical CancerRuijin HospitalPhase 1 Unknown20 enrolled
NCT04508686 2021-01-29Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)Ruijin HospitalPhase 1 Unknown20 enrolled